Division of Sleep Medicine, Henry Ford Health, Detroit, Michigan, USA.
Division of Sleep Medicine, Henry Ford Health, Detroit, Michigan, USA.
Sleep Health. 2023 Feb;9(1):18-25. doi: 10.1016/j.sleh.2022.10.010. Epub 2022 Nov 28.
In the United States, Black women are disproportionately afflicted with prenatal insomnia. Although cognitive-behavioral therapy for insomnia (CBTI) may represent a strategy to reduce disparities in insomnia, racial minorities attend fewer healthcare appointments and have poorer outcomes from prenatal care and mental health treatment relative to white patients. The present study examined differences in treatment engagement and patient-reported outcomes in non-Hispanic Black and white pregnant women receiving digital CBTI.
Secondary analysis of 39 pregnant women with clinical insomnia who received digital CBTI. Treatment engagement was operationalized as the number of sessions completed (≥4 considered an adequate dose). Treatment outcomes were assessed using the Insomnia Severity Index (ISI; insomnia) and Pittsburgh Sleep Quality Index (PSQI; global sleep disturbance).
Black women were 4 times more likely than white women to discontinue CBTI before receiving an adequate dose (8.3% vs. 33.3%). Regarding treatment outcomes, white women reported a mean reduction of 5.75 points on the ISI and a reduction of 3.33 points on the PSQI (Cohen's dz = 1.10-1.19). By comparison, Black women reported reductions of 2.13 points on the ISI and 1.53 points on the PSQI, which were statistically non-significant. Differences in treatment engagement did not account for the disparities in patient-reported outcomes.
During pregnancy, Black women completed fewer CBTI sessions and experienced poorer treatment outcomes in response to digital CBTI relative to white women. Enhancements to insomnia therapy and its digital delivery may improve adherence and outcomes in Black pregnant women.
在美国,黑种女性深受产前失眠症的困扰。尽管针对失眠的认知行为疗法(CBTI)可能是减少失眠症差异的一种策略,但与白人患者相比,少数族裔接受的医疗保健预约较少,并且在产前护理和心理健康治疗方面的效果也较差。本研究旨在探讨接受数字 CBTI 的非西班牙裔黑种和白种孕妇在治疗参与度和患者报告结果方面的差异。
对 39 名患有临床失眠症的孕妇进行二次分析,这些孕妇接受了数字 CBTI 治疗。将治疗参与度定义为完成的疗程数(完成≥4 个疗程被认为是足够的剂量)。使用失眠严重程度指数(ISI;失眠)和匹兹堡睡眠质量指数(PSQI;整体睡眠障碍)评估治疗结果。
黑种女性在接受足够剂量的 CBTI 之前停止治疗的可能性是白种女性的 4 倍(8.3%比 33.3%)。关于治疗结果,白种女性报告 ISI 平均降低 5.75 分,PSQI 降低 3.33 分(Cohen's dz=1.10-1.19)。相比之下,黑种女性报告 ISI 降低 2.13 分,PSQI 降低 1.53 分,差异无统计学意义。治疗参与度的差异并不能解释患者报告结果的差异。
在怀孕期间,与白种女性相比,黑种女性完成的 CBTI 疗程较少,并且对数字 CBTI 的反应较差。改进失眠症治疗及其数字交付可能会提高黑种孕妇的依从性和治疗效果。